- Grandis, Jennifer;
- Chiosea, SI;
- Grandis, JR;
- Lui, VWY;
- Diergaarde, B;
- Maxwell, JH;
- Ferris, RL;
- Kim, SW;
- Luvison, A;
- Miller, M;
- Nikiforova, MN
Background: Recent genomic evidence suggests frequent phosphatidylinositide 3-kinase (PI3K) pathway activation in human papillomavirus (HPV) positive oropharyngeal squamous cell carcinoma. Mutations/amplification of the gene encoding p110α catalytic subuni
